Treatment of infantile hemangiomas with propranolol: Clinical guidelines

Plastic and Reconstructive Surgery

Volumn 133, Issue 4, 2014, Pages 852-862

  Szychta, Pawel ^a   Stewart, Ken ^a   Anderson, Will ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

ARTICLE; CLINICAL PROTOCOL; COMPARATIVE STUDY; FACE TUMOR; FEMALE; HEMANGIOMA; HUMAN; INFANT; MALE; PRESCHOOL CHILD; PROSPECTIVE STUDY; SKIN TUMOR;

ADRENERGIC BETA-ANTAGONISTS; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; FACIAL NEOPLASMS; FEMALE; HEMANGIOMA; HUMANS; INFANT; MALE; PROPRANOLOL; PROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 84898015643     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0000000000000007     Document Type: Article

References (39)

1. Zimmermann AP, Wiegand S, Werner JA, Eivazi B. Propranolol therapy for infantile haemangiomas: Review of the literature. Int J Pediatr Otorhinolaryngol. 2010;74: 338-342.
2. Kilcline C, Frieden IJ. Infantile hemangiomas: How common are they? A systematic review of the medical literature. Pediatr Dermatol. 2008;25: 168-173.
3. Frieden IJ, Eichenfield LF, Esterly NB, Geronemus R, Mallory SB. Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee. J Am Acad Dermatol. 1997;37: 631-637.
4. Sans V, de la Roque ED, Berge J, et al. Propranolol for severe infantile hemangiomas: Follow-up report. Pediatrics 2009;124:e423-e431.
5. Buckmiller L, Dyamenahalli U, Richter GT. Propranolol for airway hemangiomas: Case report of novel treatment. Laryngoscope 2009;119: 2051-2054.
6. Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian EN. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol. 2009;73: 1168-1172.
7. Manunza F, Syed S, Laguda B, et al. Propranolol for complicated infantile haemangiomas: A case series of 30 infants. Br J Dermatol. 2010;162: 466-468.
8. Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: Risks and recommendations. Pediatr Dermatol. 2009;26: 610-614.
9. Qin ZP, Liu XJ, Li KL, Zhou Q, Yang XJ, Zheng JW. [Treatment of infantile hemangiomas with low-dose propranolol: Evaluation of short-term efficacy and safety]. Zhonghua Yi Xue Za Zhi 2009;89: 3130-3134.
10. Buckmiller LM. Propranolol treatment for infantile hemangiomas. Curr Opin Otolaryngol Head Neck Surg. 2009;17: 458-459.
11. Holmes WJ, Mishra A, Gorst C, Liew SH. Propranolol as firstline treatment for infantile hemangiomas. Plast Reconstr Surg. 2010;125: 420-421.
12. Jephson CG, Manunza F, Syed S, Mills NA, Harper J, Hartley BE. Successful treatment of isolated subglottic haemangioma with propranolol alone. Int J Pediatr Otorhinolaryngol. 2009;73: 1821-1823.
13. Theletsane T, Redfern A, Raynham O, Harris T, Prose NS, Khumalo NP. Life-threatening infantile haemangioma: A dramatic response to propranolol. J Eur Acad Dermatol Venereol. 2009;23: 1465-1466.
14. Marsciani A, Pericoli R, Alaggio R, Brisigotti M, Vergine G. Massive response of severe infantile hepatic hemangioma to propanolol. Pediatr Blood Cancer 2010;54:176.
15. Fay A, Nguyen J, Jakobiec FA, Meyer-Junghaenel L, Waner M. Propranolol for isolated orbital infantile hemangioma. Arch Ophthalmol. 2010;128: 256-258.
16. Bigorre M, Van Kien AK, Valette H. Beta-blocking agent for treatment of infantile hemangioma. Plast Reconstr Surg. 2009;123:195e-196e.
17. Tan ST, Itinteang T, Leadbitter P. Low-dose propranolol for infantile haemangioma. J Plast Reconstr Aesthet Surg. 2011;64: 292-299.
18. Bingham MM, Saltzman B, Vo NJ, Perkins JA. Propranolol reduces infantile hemangioma volume and vessel density. Otolaryngol Head Neck Surg. 2012;147: 338-344.
19. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69: 412-422.
20. Al Dhaybi R, Superstein R, Milet A, et al. Treatment of periocular infantile hemangiomas with propranolol: Case series of 18 children. Ophthalmology 2011;118: 1184-1188.
21. Szychta P, Al-Nakib K, Anderson W, Stewart K, Quaba A. Quantitative method for evaluation of aesthetic results after laser treatment for birthmarks. Lasers Med Sci. 2013;28: 1567-1572.
22. Szychta P, Witmanowski H, Rykala J. Assessment of 3D scanner usefulness in aesthetic evaluation of posttraumatic rhinoplasty. J Plast Surg Hand Surg. 2013;47: 106-112.
23. Zhang L, Lin X, Wang W, et al. Circulating level of vascular endothelial growth factor in differentiating hemangioma from vascular malformation patients. Plast Reconstr Surg. 2005;116: 200-204.
24. Enjolras O, Wassef M, Chapot R. Color Atlas of Vascular Tumors and Vascular Malformations. Cambridge, United Kingdom: Cambridge University Press; 2007.
25. Eivazi B, Ardelean M, Bäumler W, et al. Update on hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol. 2009;266: 187-197.
26. Corella F, Garcia-Navarro X, Ribe A, Alomar A, Baselga E. Abortive or minimal-growth hemangiomas: Immunohistochemical evidence that they represent true infantile hemangiomas. J Am Acad Dermatol. 2008;58: 685-690.
27. Brandling-Bennett HA, Metry DW, Baselga E, et al. Infantile hemangiomas with unusually prolonged growth phase: A case series. Arch Dermatol. 2008;144: 1632-1637.
28. Haggstrom AN, Lammer EJ, Schneider RA, Marcucio R, Frieden IJ. Patterns of infantile hemangiomas: New clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006;117: 698-703.
29. Maguiness SM, Frieden IJ. Current management of infantile hemangiomas. Semin Cutan Med Surg. 2010;29: 106-114.
30. Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: Implications for management. Pediatrics 2008;122: 360-367.
31. Williams EF 3rd, Stanislaw P, Dupree M, Mourtzikos K, Mihm M, Shannon L. Hemangiomas in infants and children: An algorithm for intervention. Arch Facial Plast Surg. 2000;2: 103-111.
32. Hynes S, Narasimhan K, Courtemanche DJ, Arneja JS. Complicated infantile hemangioma of the lip: Outcomes of early versus late resection. Plast Reconstr Surg. 2013;131:373e-379e.
33. Baetz J, Eigelshoven S, Marquard J, Bruch-Gerharz D, Homey B, Meissner T. [Infantile hemangioma: Successful treatment with propranolol]. Hautarzt 2010;61: 290-292.
34. Holmes WJ, Mishra A, Gorst C, Liew SH. Propranolol as firstline treatment for rapidly proliferating infantile haemangiomas. J Plast Reconstr Aesthet Surg. 2011;64: 445-451.
35. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for haemangiomas of infancy. N Engl J Med. 2008;359: 2846-2847.
36. Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol. 2003;48:477-493; quiz 494.
37. Fay A, Nguyen J, Waner M. Conceptual approach to the management of infantile hemangiomas. J Pediatr. 2010;157:881-888.e1-5.
38. Michel JL, Patural H. [Response to oral propranolol therapy for ulcerated hemangiomas in infancy]. Arch Pediatr. 2009;16: 1565-1568.
39. Guo S, Ni N. Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution. Arch Ophthalmol. 2010;128: 255-256.